Chronic daily headaches in children

Expert Opinion on Pharmacotherapy

Volumn 4, Issue 4, 2003, Pages 485-491

  Hershey, Andrew D ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Headaches; Paediatric disorders; Pain

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIMIGRAINE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYPROHEPTADINE; DIHYDROERGOTAMINE; GABAPENTIN; IBUPROFEN; LAMOTRIGINE; MAGNESIUM; METHYSERGIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROCHLORPERAZINE; PROPRANOLOL; RIBOFLAVIN; SEROTONIN ANTAGONIST; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM;

BEHAVIOR THERAPY; BODY WEIGHT DISORDER; CHILD; CHRONIC PAIN; CLINICAL FEATURE; CLUSTER HEADACHE; COGNITIVE DEFECT; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG BIOAVAILABILITY; HEADACHE; HUMAN; MIGRAINE; OVARY CYST; PARESTHESIA; REBOUND; RELAXATION TRAINING; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT; SOMNOLENCE; SYMPTOMATOLOGY; WEIGHT GAIN; WEIGHT REDUCTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; EXPERT TESTIMONY; HEADACHE DISORDERS; HUMANS;

EID: 0037396841     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.4.4.485     Document Type: Review

References (63)

1. LIPTON RB, STEWART WF: Prevalence and impact of migraine. Neurol. Clin. (1997) 15:1-13.
2. CASTILLO J, MUÑOZ P, GUITERA V, PASCUAL J: Epidemiology of chronic daily headache in the general population. Headache (1999) 39:190-196.
3. SILLANPÄÄ M, PIEKKALA P, KERO P: Prevalence of headache at preschool age in an unselected child population. Cephalalgia (1991) 11:239-242.
4. ABU-AREFEH I, RUSSELL G: Prevalence of headache and migraine in schoolchildren. Br. Med. J. (1994) 309:765-769.
5. OSTERHAUS JT, TOWNSEND RJ, GANDEK B, WARE JE Jr: Measuring the functional status and well-being of patients with migraine headache. Headache (1994) 34:337-343.
6. STEWART WF, LIPTON RB, KOLODNER K, LIBERMAN J, SAWYERJ: Reliability of the migraine disability assessment score in a population-based sample of headache suffers. Cephalalgia (1999) 19:107-114.
7. STEWART WF, LIPTON RB, WHYTE J et al.: An international study to assess reliability of the migraine disability assessment (MIDAS) score. Neurology (1999) 53:988-994.
8. STEWART WF, LIPTON RB, KOLODNER KB et al.: Validity of the migraine disability assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain (2000) 88:41-52.
9. HOLMES WE, MACGREGOR EA, SAWYER JPC, LIPTON RB: Information about migraine disability influences physicians' perceptions of illness severity and treatment needs. Headache (2001) 41:343-350.
10. LIPTON RB SILBERSTEIN SD: The role of headache-related disability in migraine management: implications for headache treatment guidelines. Neurology (2001) 56(Suppl. 1):S35-S42.
11. HERSHEY AD, POWERS SW, VOCKELL ALB, et al.: PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology (2001) 57(11):2034-2039.
12. HU XH, MARKSON LE, LIPTON RB, STEWART WF, BERGER ML: Burden of migraine in the United States: disability and economic costs. Arch. Intern. Med. (1999) 159:813-818.
13. SCHWARTZ BS, STEWART WF, LIPTON RB: Lost work-days and decreased work effectiveness associated with headache in the workplace. J. Occup. Environ. Med (1997) 39:320-327.
14. VON KORFF M, STEWART WF, SIMON DJ, LIPTON RB: Migraine and reduced work performance: a population-based diary study. Neurology (1998) 50:1741-1745.
15. RASMUSSEN BK, JANSEN R, OLESEN J: Impact of headache on sickness absence and utilization of medical services: a Danish population study. J. Epidemiol. Community Health (1992) 46(4):443-446.
16. EDMEADS J, MACKELL JA: The economic impact of migraine: an analysis of direct and indirect costs. Headache (2002) 42:501-509.
17. INTERNATIONAL HEADACHE SOCIETY. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cophalalgia (1988) 8(S7):S1-S96.
18. SILBERSTEIN SD, LIPTON RB, SOLOMON S, MATHEW NT: Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache (1994) 34:1-7.
19. SILBERSTEIN SD, LIPTON RB, SLIWINSKI M: Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology (1996) 47:871-875.
20. GLADSTEIN J, HOLDEN EW: Chronic daily headache in children and adolescents: a 2-year prospective study. Headache (1996) 36:349-351.
21. KOENIG MA, GLADSTEIN J, MCCARTER RJ et al.: Chronic daily headache in children and adolescents presenting to tertiary headache clinics. Headache (2002) 42:491-500.
22. HERSHEY AD, POWERS SW BENTTI A-L, LECATES SL, DEGRAUW A: Characterization of chronic daily headaches in children in a multidisciplinary headache center. Neurology (2001) 56:1032-1037.
23. ROTHROCK JF: Management of chronic daily headache utilizing a uniform treatment pathway. Headache (1999) 39:650-653.
24. HÄMÄLÄINEN ML, HOPPU K, VALKEILA E, SANTAVUORI P: Ibuprofen or acetaminophen for the acute treatment of migraine in children. Neurology (1997) 48:103-107.
25. LEWIS D, KELLSTEIN D, DAHL G et al.: Children's ibuprofen suspension for the acute treatment pediatric migraine. Headache (2002) 42:780-786.
26. WANG S-J, FUH J-L, LU S-R et al.: Chronic daily headache in Chinese elderly: prevalence, risk factors and biannual follow-up. Neurology (2000) 54:314-319.
27. VASCONCELLOS E, PINA-GARZA JE, MILLAN EJ, WARNER JS: Analgesic rebound headache in children and adolescents.J. Child. Neurol. (1998) 13(9):443-447.
28. PINI LA, TRENTI T: Case report: does chronic use of sumatriptan induce dependence? Headache (1994) 34:600-601.
29. LIMMROTH V, KAZARAWA Z, FRITSCHE G, DIENER HC: Headache after frequent use of serotonin agonist zolmitriptan and naratriptan. Lancet (1999) 353(9150):378.
30. KATSARAVA Z, MUEBIG M, FRITSCHE G, DIENER HC, LIMMROTH V: Clinical features of withdrawal headache following overuse of triptans in comparison to other anti-headache drugs. Neurology (2001) 57:1694-1698.
31. LIMMROTH V, KATSARAVA Z, FRITSCHE G, PRZYWARA S, DIENER HC: Features of medication overuse headache following overuse of different acute headache drugs. Neurology (2002) 59:1011-1014.
32. LINTON-DAHLÖF P, LINDE M, DAHLÖF C: Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia (2000) 20:658-662.
33. KABBOUCHE M, VOCKELL ALB, LECATES SL, POWERS SW, HERSHEY AD: Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics (2001) 107(4):e62.
34. LINDER S: Treatment of childhood headache with dihydroergoramine mesylate. Headache (1994) 34:578-580.
35. SRIKIATKHACHORN A, TARASUB N, GOVITRAPONG P: Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache (2000) 40:343-350.
36. LIPTON RB, STEWART WF, CADY R et al.: Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache (2000) 40:783-791.
37. CADY R, RYAN R, JHINGRAN P, OQUINN S, PAIT D: Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. Arch. Intern. Med. (1998) 9:1013-1018.
38. WINNER P, ROTHNER D, SAPER J et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acure migraine in adolescents. Pediatrics (2000) 106:989-997.
39. WINNER P, SAPER JR, NETT R et al.: Sumatriptan nasal spray in the acute treatment of migraine in adolescent migraineurs. Headache (1999) 39(5):386.
40. UEBERALL MA, WENZEL D: Intranasal sumatriptan for the acute treatment of migraine in children. Neurology (1999) 52:1507-1510.
41. HERSHEY AD, POWERS SW, LECATES SL, BENTTI A-L: Effectiveness of nasal sumatriptan in 5 to 12 year old children. Headache (2001) 7:693-697.
42. MACDONALD J: Treatment of juvenile migraine with subcutaneous sumatriptan. Headache (1994) 34:581-582.
43. HÄMÄLÄINEN ML, HOPPU K, SANTAVUORI P: Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Neurology (1997) 48:1100-1103.
44. UNDER SL: Subcutaneous sumatriptan in the clinical setting: the first fifty consecutive patients with acute migraine in a pediatric neurology office practice. Headache (1995) 35:291-292.
45. REDILLAS C, SOLOMON S: Prophylactic pharmacological treatment of chronic daily headache. Headache (2000) 40:83-102.
46. HERSHEY AD, POWERS SW, BENTTI A-L, DEGRAUW TJ: Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache (2000) 40:539-549.
47. LANDY S, MCGINNIS J, CURLIN D, LAIZURE C: Selective serotonin reuptake inhibitors for migraine prophylaxis. Headache (1999) 39:28-32.
48. MATHEW N, SAPER J, SILBERSTEIN S et al.: migraine prophylaxis with divalproex. Arch. Neurol. (1995) 52:281-286.
49. FREITAG F, DIAMOND S, DIAMOND ML, URBAN Gj: Divalproex in the long-term treatment of chronic daily headache. Headache (2001) 41:271-278.
50. FREITAG F, COLLINS SD, CARLSON HA et al: A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology (2002) 58:1652-1659.
51. CARUSO JM, BROWN WD, EXIL G, GASCON GG: The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache (2000) 40:672-676.
52. MATHEW NT, RAPOPORT A, SAPER J et al.: Efficacy of gabapentin in migraine prophylaxis. Headache (2001) 41:119-128.
53. D'ANDREA G, GRANELLA E CADALDINI M, MANZONI GC: Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia (1999) 19:64-66.
54. LAMPL C, BUZATH A, KLINGER D, NEUMAN K: Lamotrigine in the prophylactic treatment of migraine aura - a pilot study. Cephalalgia (1999) 19:58-63.
55. EDWARDS KR, GLANTZ MJ, SHEA P, NORTONJA: A double-blind, randomized trial of topiramate versus placebo in the prophylactic treatment of migraine headache with and without aura. 18th Annual Scientific Meeting, American Pain Society. Fort Lauderdale, USA (1999).
56. POTTER DL, HART DE, CALDER CS STOREY JR: A double-blind, randomized, placebo-controlled, parallel study to determine the efficacy of topiramate in the prophylactic treatment of migraine. Neurology (2000) 54(Suppl. 3)A15.
57. HERSHEY AD, POWERS SW VOCKELL ALB, LECATES SL, KABBOUCHE MA: Effectiveness of topiramate in the prevention of childhood headaches. Headache (2002) 42:810-818.
58. BILLE B, LUDVIGSSON J, SANNER G: Prophylaxis of migraine in children. Headache (1977) 17:61-63.
59. LUDVIGSSON J: Propranolol used in prophylaxis of migraine in children. Acta Neurol. Scand. (1974) 50:109-115.
60. DUCKRO PN, CANTWELL-SIMMONS E: A Review of studies evaluating biofeedback and relaxation training in the management of pediatric headache. Headache (1989) 29:428-433.
61. POWERS SW, HERSHEY AD: Biofeedback for childhood migraine. In: current management in child neurology. B. L. Maria (Ed.), BC Decker, Hamiltion, Ontario, Canada (2002):83-85.
62. POWERS SW, MITCHELL MJ, BYARS KC et al.: Effectiveness of one-session biofeedback training in a pediatric headache center: a pilot study. Neurology (2000): (In Press).
63. JUANT K-D, WANG S-J, FUH J-L, LU S-R, SU T-P: Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache (2000) 40:818-823.